179
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Dietary therapies for eosinophilic esophagitis

&

References

  • Liacouras CA, Furuta GT, Hirano I et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J. Allergy Clin. Immunol. 128(1), 3–20 (2011).
  • DeBrosse CW, Franciosi JP, King EC et al. Long-term outcomes in pediatric-onset esophageal eosinophilia. J. Allergy Clin. Immunol. 128(1), 132–138 (2011).
  • Taft TH, Kern E, Kwiatek MA, Hirano I, Gonsalves N, Keefer L. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment. Pharmacol. Ther. 34(7), 790–798 (2011).
  • Franciosi JP, Hommel KA, DeBrosse CW et al. Quality of life in paediatric eosinophilic oesophagitis: what is important to patients? Child. Care Health Dev. 38(4), 477–483 (2012).
  • Arias Á, Lucendo AJ. Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain. Eur. J. Gastroenterol. Hepatol. 25(2), 208–212 (2013).
  • Hruz P, Straumann A, Bussmann C et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J. Allergy Clin. Immunol. 128(6), 1349–1350 (2011).
  • Prasad GA, Alexander JA, Schleck CD et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin. Gastroenterol. Hepatol. 7(10), 1055–1061 (2009).
  • Noel R. Eosinophilic esophagitis. N. Engl. J. Med. 351(9), 940–941 (2004).
  • Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig. Dis. Sci. 38(1), 109–116 (1993).
  • Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vögtlin J. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz. Med. Wochenschr. 124(33, 1419–1429 (1994).
  • Lucendo AJ, Arias A, Molina-Infante J et al. Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice. Dig. Liver Dis. 45(7), 562–568 (2013).
  • Lucendo AJ, Sánchez-Cazalilla M. Adult versus pediatric eosinophilic esophagitis: Important differences and similarities for the clinician to understand. Expert Rev. Clin. Immunol. 8(8), 733–745 (2012).
  • Konikoff MR, Noel RJ, Blanchard C et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131(5), 1381–1391 (2006).
  • Noel RJ, Putnam PE, Collins MH et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 2(7), 568–575 (2004).
  • Teitelbaum JE, Fox VL, Twarog FJ et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 122(5), 1216–1225 (2002).
  • Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 139(2), 418–429 (2010).
  • Straumann A, Conus S, Degen L et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 9(5), 400–409 (2011).
  • Liacouras CA, Spergel JM, Ruchelli E et al. Eosinophilic esophagitis: A 10-year experience in 381 children. Clin. Gastroenterol. Hepatol. 3(12), 1198–206 (2005).
  • Lucendo AJ, De Rezende LC, Jiménez-Contreras S et al. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis. Dig. Dis. Sci. 56(12), 3551–3558 (2011).
  • Chong C-R, Neil CJ, Nguyen TH, Singh K, Horowitz JD. Letters to the Editor. Clin. Cardiol. 122(2), 425–427 (2013).
  • Rocha R, Vitor AB, Trindade E et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur. J. Pediatr. 170(11), 1471–1474 (2011).
  • Straumann a, Conus S, Grzonka P et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 59(1), 21–30 (2010).
  • Assa’ad AH, Gupta SK, Collins MH et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 141(5), 1593–1604 (2011).
  • Spergel JM, Rothenberg ME, Collins MH et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 129(2), 456–463 (2012).
  • Moawad FJ, Cheatham JG, Dezee KJ. Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment. Pharmacol. Ther. 38(7), 713–720 (2013).
  • Schoepfer AM, Gonsalves N, Bussmann C et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am. J. Gastroenterol. 105(5), 1062–1070 (2010).
  • Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 109(5), 1503–1512 (1995).
  • Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am. J. Gastroenterol. 98(4), 777–782 (2003).
  • Kagalwalla AF, Sentongo TA, Ritz S et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 4(9), 1097–1102 (2006).
  • Kagalwalla AF, Amsden K, Shah A et al. Cow’s milk elimination: a novel dietary approach to treat eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr. 55(6), 711–716 (2012).
  • Henderson CJ, Abonia JP, King EC et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J. Allergy Clin. Immunol. 129(6), 1570–1578 (2012).
  • Spergel JM, Brown-Whitehorn TF, Cianferoni A et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J. Allergy Clin. Immunol. 130(2), 461–467 (2012).
  • Peterson KA, Byrne KR, Vinson LA et al. Elemental Diet Induces Histologic Response in Adult Eosinophilic Esophagitis. Am. J. Gastroenterol. 108(5), 759–766 (2013).
  • Ferreira CT, Vieira MC, Vieira SMG, Silva GS da, Yamamoto DR, Silveira TR da. Eosinophilic esophagitis in 29 pediatric patients. Arq. Gastroenterol. 45(2), 141–146 (2008).
  • De Agustin JC, Sanz N, Canals MJ et al. Successful medical treatment of two patients with eosinophilic oesophagitis. J. Pediatr. Surg. 37(2), 207–213 (2002).
  • Al-Hussaini A, Al-Idressi E, Al-Zahrani M. The role of allergy evaluation in children with eosinophilic esophagitis. J. Gastroenterol. doi:10.1007/s00535-012-0741-6 (2013) ( Epub ahead of print).
  • Abu-Sultaneh SMA, Durst P, Maynard V, Elitsur Y. Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis. Dig. Dis. Sci. 56(1), 97–102 (2011).
  • Basilious A, Liem J. Nutritional management of Eosinophilic Gastroenteropathies: Case series from the community. Allergy Asthma Clin. Immunol. 7, 10 (2011).
  • Pascual JMR, Caballer BH, Verge CR et al. Allergy assessment in children with eosinophilic esophagitis. J. Investig. Allergol. Clin. Immunol. 21(1), 59–65 (2011).
  • Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J. Allergy Clin. Immunol. 109(2), 363–368 (2002).
  • Spergel JM, Brown-Whitehorn T. The use of patch testing in the diagnosis of food allergy. Curr. Allergy Asthma Rep. 5(1), 86–90 (2005).
  • Spergel JM, Brown-Whitehorn TF, Beausoleil JL et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J. Pediatr. Gastroenterol. Nutr. 48(1), 30–36 (2009).
  • Henderson CJ, Collins MH, Abonia JP, Putnam PE, Rothenberg ME. Reply. J. Allergy Clin. Immunol. 131(1), 613–614 (2013).
  • Boyce JA, Assa’ad A, Burks AW et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J. Allergy Clin. Immunol. 126(6), 1105–1118 (2010).
  • Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, Porcel-Carreño SL, Jimenez-Timon S, Hernandez-Arbeiza FJ. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J. Allergy Clin. Immunol. 130(5), 1200–1202 (2012).
  • Simon D, Straumann A, Wenk A, Spichtin H, Simon H-U, Braathen LR. Eosinophilic esophagitis in adults – No clinical relevance of wheat and rye sensitizations. Allergy 61(12), 1480–1483 (2006).
  • Quaglietta L, Coccorullo P, Miele E, Pascarella F, Troncone R, Staiano A. Eosinophilic oesophagitis and coeliac disease: Is there an association?. Aliment. Pharmacol. Ther. 26(3), 487–493 (2007).
  • Gonzalez-Cervera J, Angueira T, Rodriguez-Dominguez B et al. Successful food elimination therapy in adult eosinophilic esophagitis: not all patients are the same. J. Clin. Gastroenterol. 46(10), 855–858 (2012).
  • Lucendo AJ, Lucendo B. An update on the immunopathogenesis of eosinophilic esophagitis. Expert Rev. Gastroenterol. 4(2), 141–148 (2010).
  • Paquet B, Bégin P, Paradis L, Drouin E, Des Roches A. Variable yield of allergy patch testing in children with eosinophilic esophagitis. J. Allergy Clin. Immunol. 131(2), 613 (2013).
  • Rizo Pascual JM, De La Hoz Caballer B, Redondo Verge C et al. Allergy assessment in children with eosinophilic esophagitis. J. Investig. Allergol. Clin. Immunol. 21(1), 59–65 (2011).
  • Assa’ad AH, Putnam PE, Collins MH et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J. Allergy Clin. Immunol. 119(3), 731–738 (2007).
  • Gonsalves N, Yang G-YG-Y, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; Food reintroduction identifies causative factors. Gastroenterology 142(7), 1451–1459. (2012).
  • Lucendo AJ, Arias A, González-Cervera J et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: A prospective study on the food cause of the disease. J. Allergy Clin. Immunol. 131(3), 797–804 (2013).
  • Sanchez-Garcia S, Rodriguez Del Rio P, Escudero C et al. Possible eosinophilic esophagitis induced by milk oral immunotherapy. J. Allergy Clin. Immunol. 129(4), 1155–1157 (2012).
  • Ridolo E, De Angelis GL, Dall’aglio P. Eosinophilic esophagitis after specific oral tolerance induction for egg protein. Ann. Allergy Asthma Immunol. 106(1), 73–74 (2011).
  • Stewart MJ, Shaffer E, Urbanski SJ, Beck PL, Storr M a. The association between celiac disease and eosinophilic esophagitis in children and adults. BMC Gastroenterol. 13(1), 96 (2013).
  • Lucendo AJ, Arias Á, Pérez-Martínez I et al. Adult patients with eosinophilic esophagitis do not show an increased frequency of the HLA-DQ2/DQ8 genotypes predisposing to celiac disease. Dig. Dis. Sci. 56(4), 1107–1111 (2011).
  • Verzegnassi F, Bua J, De Angelis P, Dall’Oglio L, Di Leo G, Ventura A. Eosinophilic oesophagitis and coeliac disease: is it just a casual association? Gut 56(7), 1029–1030 (2007).
  • Ooi CY, Day AS, Jackson R, Bohane TD, Tobias V, Lemberg DA. Eosinophilic esophagitis in children with celiac disease. J. Gastroenterol. Hepatol. 23(7 pt 1), 1144–1148 (2008).
  • Leslie C, Mews C, Charles A, Ravikumara M. Celiac disease and eosinophilic esophagitis: A true association. J. Pediatr. Gastroenterol. Nutr. 50(4), 397–399 (2010).
  • Kagalwalla AF, Shah A, Li BUK et al. Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J. Pediatr. Gastroenterol. Nutr. 53(2), 145–149 (2011).
  • Gonsalves N, Doerfler B, Hirano I. Long term maintenance therapy with dietary restriction in adults with eosinophilic esophagitis. Gastroenterology 140 ( 5, Suppl. 1), S180–S181 (2011).
  • McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest. Endosc. 67(6), 910–23 (2008).
  • Karen T, Schlager GW, Bendix I et al. Effect of propofol in the immature rat brain on short- and long-term neurodevelopmental outcome. PLoS ONE 8(5), e64480 (2013).
  • Popic J, Pesic V, Milanovic D et al. Propofol-induced changes in neurotrophic signaling in the developing nervous system in vivo. PLoS ONE 7(4), e34396 (2012).
  • Buehrer S, Immoos S, Frei M, Timmermann B, Weiss M. Evaluation of propofol for repeated prolonged deep sedation in children undergoing proton radiation therapy. Br. J. Anaesth. 99(4), 556–560 (2007).
  • Furuta GT, Kagalwalla AF, Lee JJ et al. The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut 62(10), 1395–1405 (2013).
  • Simon D, Straumann a, Dahinden C, Simon H-U. Frequent sensitization to Candida albicans and profilins in adult eosinophilic esophagitis. Allergy 68(7), 945–948 (2013).
  • Lucendo AJ, Arias Á, González-Cervera J, Mota-Huertas T, Yagüe-Compadre JL. Tolerance of a cow’s milk-based hydrolyzed formula in patients with eosinophilic esophagitis triggered by milk. Allergy 68(8), 1065–1072 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.